BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Seifert LL, Perumpail RB, Ahmed A. Update on hepatitis C: Direct-acting antivirals. World J Hepatol 2015; 7(28): 2829-2833 [PMID: 26668694 DOI: 10.4254/wjh.v7.i28.2829]
URL: https://www.wjgnet.com/1948-5182/full/v7/i28/2829.htm
Number Citing Articles
1
Kathleen A. McGinnis, Matthew S. Suffoletto. The U. S. Department of Veterans Affairs (VA) as a model for stronger public health infrastructure to combat HCV and other infectious diseases and reduce disparitiesEClinicalMedicine 2020; 22: 100391 doi: 10.1016/j.eclinm.2020.100391
2
Alyssa M. Austria, Vjera Ninčević, George Y. Wu. Update on Hepatitis C2017;  doi: 10.5772/intechopen.70685
3
Kathleen N Ly, Arialdi M Miniño, Stephen J Liu, Henry Roberts, Elizabeth M Hughes, John W Ward, Ruth B Jiles. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016–2017Clinical Infectious Diseases 2020; 71(5): 1149 doi: 10.1093/cid/ciz976
4
Lingbao Kong, Akira Fujimoto, Mariko Nakamura, Haruyo Aoyagi, Mami Matsuda, Koichi Watashi, Ryosuke Suzuki, Minetaro Arita, Satoshi Yamagoe, Naoshi Dohmae, Takehiro Suzuki, Yuriko Sakamaki, Shizuko Ichinose, Tetsuro Suzuki, Takaji Wakita, Hideki Aizaki, J.-H. J. Ou. Prolactin Regulatory Element Binding Protein Is Involved in Hepatitis C Virus Replication by Interaction with NS4BJournal of Virology 2016; 90(6): 3093 doi: 10.1128/JVI.01540-15
5
Anjiya Shaikh, Karthik Goli, Tzu-Hao Lee, Nicole E. Rich, Jihane N. Benhammou, Stephanie Keeling, Donghee Kim, Aijaz Ahmed, John Goss, Abbas Rana, Amit G. Singal, Fasiha Kanwal, George Cholankeril. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral EraClinical Gastroenterology and Hepatology 2023; 21(9): 2288 doi: 10.1016/j.cgh.2022.11.038
6
Thein Min Swe, Derek. C. Johnson, Htay Thet Mar, Phone Thit, Tobias Homan, Cherry May Chu, Phyu Ei Mon, Thin Thin Thwe, Kyi Pyar Soe, Win Le Shwe Sin Ei, Nyan Lynn Tun, Kyaw Zay Lwin, Hayk Karakozian, Khin Sanda Aung, Aude Nguyen, Iza Ciglenecki, Natalia Tamayo, Anne Loarec. Epidemiological characteristics and real‐world treatment outcomes of hepatitis C among HIV/HCV co‐infected patients in Myanmar: A prospective cohort studyHealth Science Reports 2023; 6(2) doi: 10.1002/hsr2.1119
7
Tomohiro Tanaka, Krista L. Lentine, Qianyi Shi, Mark Vander Weg, David A. Axelrod. Differential Impact of the UNOS Simultaneous Liver-kidney Transplant Policy Change Among Patients With Sustained Acute Kidney InjuryTransplantation 2024; 108(3): 724 doi: 10.1097/TP.0000000000004774
8
Kathleen N. Ly, Justin K. Niles, Ruth B. Jiles, Harvey W. Kaufman, Mark K. Weng, Priti Patel, William A. Meyer, William W. Thompson, Nicola D. Thompson. Hepatitis C Virus Testing, Infection, and Cases Reported Through Public Health Surveillance During Expanded Screening Recommendations, United States, 2013-2021Public Health Reports 2024;  doi: 10.1177/00333549231224199
9
François Girardin, Natalie Hearmon, Francesco Negro, Lucy Eddowes, Philip Bruggmann, Erika Castro. Increasing hepatitis C virus screening in people who inject drugs in Switzerland using rapid antibody saliva and dried blood spot testing: A cost‐effectiveness analysisJournal of Viral Hepatitis 2019; 26(2): 236 doi: 10.1111/jvh.13023
10
Takako Inoue, Tomoyuki Ohike, Kumiko Ohne, Shigeru Sato, Takaaki Goto, Yasuhito Tanaka. Clinical Evaluation of a Newly Developed Chemiluminescent Enzyme Immunoassay for Hepatitis C Virus Core Antigen in JapanJapanese Journal of Infectious Diseases 2019; 72(5): 285 doi: 10.7883/yoken.JJID.2018.472
11
Reza Taherkhani, Fatemeh Farshadpour. Lurking epidemic of hepatitis C virus infection in Iran: A call to actionWorld Journal of Hepatology 2017; 9(24): 1040-1042 doi: 10.4254/wjh.v9.i24.1040
12
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and ImmunizationJournal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
13
A. M. Buchanan-Hughes, M. Buti, K. Hanman, B. Langford, M. Wright, L. A. Eddowes. Health state utility values measured using the EuroQol 5-dimensions questionnaire in adults with chronic hepatitis C: a systematic literature review and meta-analysisQuality of Life Research 2019; 28(2): 297 doi: 10.1007/s11136-018-1992-3
14
Erica Diani, Anna Lagni, Virginia Lotti, Emil Tonon, Riccardo Cecchetto, Davide Gibellini. Vector-Transmitted Flaviviruses: An Antiviral Molecules OverviewMicroorganisms 2023; 11(10): 2427 doi: 10.3390/microorganisms11102427
15
Edward J. Gane, Christian Schwabe, Robert H. Hyland, Yin Yang, Evguenia Svarovskaia, Luisa M. Stamm, Diana M. Brainard, John G. McHutchison, Catherine A. Stedman. Efficacy of the Combination of Sofosbuvir, Velpatasvir, and the NS3/4A Protease Inhibitor GS-9857 in Treatment-Naïve or Previously Treated Patients With Hepatitis C Virus Genotype 1 or 3 InfectionsGastroenterology 2016; 151(3): 448 doi: 10.1053/j.gastro.2016.05.021
16
Ergenekon Karagöz, Alpaslan Tanoğlu, Asim Ülçay, Hakan Erdem, Vedat Turhan, Muammer Kara, Yusuf Yazgan. Mean platelet volume and red cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in patients with chronic hepatitis CEuropean Journal of Gastroenterology & Hepatology 2016; 28(7): 744 doi: 10.1097/MEG.0000000000000647
17
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled TrialsJournal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
18
Napas Rodprasert, Tinn Hongboontry, Chitchanok Cherdchoochart, Roongruedee Chaiteerakij. Association between Liver Stiffness and Liver-Related Events in HCV-Infected Patients after Successful Treatment with Direct-Acting AntiviralsMedicina 2023; 59(3): 602 doi: 10.3390/medicina59030602
19
Takako Inoue, Su Su Hmwe, Noritomo Shimada, Keizo Kato, Tatsuya Ide, Takuji Torimura, Takashi Kumada, Hidenori Toyoda, Akihito Tsubota, Koichi Takaguchi, Takaji Wakita, Yasuhito Tanaka, Ranjit Ray. Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based TherapyPLOS ONE 2017; 12(1): e0170667 doi: 10.1371/journal.pone.0170667
20
Sherif M. Shawky, Ahmed M. Awad, Walaa Allam, Mohamed H. Alkordi, Sherif F. EL-Khamisy. Gold aggregating gold: A novel nanoparticle biosensor approach for the direct quantification of hepatitis C virus RNA in clinical samplesBiosensors and Bioelectronics 2017; 92: 349 doi: 10.1016/j.bios.2016.11.001
21
Ana Virseda-Berdices, Oscar Brochado-Kith, Cristina Díez, Victor Hontañon, Juan Berenguer, Juan González-García, David Rojo, Amanda Fernández-Rodríguez, Luis Ibañez-Samaniego, Elba Llop-Herrera, Antonio Olveira, Leire Perez-Latorre, Coral Barbas, Marta Rava, Salvador Resino, María Angeles Jiménez-Sousa. Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosisJournal of Antimicrobial Chemotherapy 2022; 77(3): 719 doi: 10.1093/jac/dkab444
22
Melanie L Yarbrough, Carey-Ann D Burnham. The ABCs of STIs: An Update on Sexually Transmitted InfectionsClinical Chemistry 2016; 62(6): 811 doi: 10.1373/clinchem.2015.240234
23
Xi Khai Wong, Chen Seng Ng, Keng Yoon Yeong. Shaping the future of antiviral Treatment: Spotlight on Nucleobase-Containing drugs and their revolutionary impactBioorganic Chemistry 2024; 144: 107150 doi: 10.1016/j.bioorg.2024.107150
24
Muhammad Nauman Zahid. Transplantation of Organs from Hepatitis C Virus-Positive Donors under Direct-Acting Antiviral RegimensJournal of Clinical Medicine 2022; 11(3): 770 doi: 10.3390/jcm11030770
25
Takako Inoue, Takaaki Goto, Etsuko Iio, Kayoko Matsunami, Kei Fujiwara, Noboru Shinkai, Kentaro Matsuura, Takeshi Matsui, Shunsuke Nojiri, Yasuhito Tanaka. Changes in serum lipid profiles caused by three regimens of interferon‐free direct‐acting antivirals for patients infected with hepatitis C virusHepatology Research 2018; 48(3) doi: 10.1111/hepr.12970